Comprehensive and Personalized Approach to Managing mHSPC: Fitting the Right Pieces for Each Patient

Did you know that limiting genetic testing to castration-resistant disease is subpar to testing at the hormone-sensitive stage in prostate cancer? Credit available for this activity expires: 01/09/26

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002043?ecd=bdc_podcast_libsyn_mscpedu